Home/Filings/4/0000950170-24-042372
4//SEC Filing

Kim Hanjoon Alex 4

Accession 0000950170-24-042372

CIK 0001162194other

Filed

Apr 4, 8:00 PM ET

Accepted

Apr 5, 6:58 PM ET

Size

9.0 KB

Accession

0000950170-24-042372

Insider Transaction Report

Form 4
Period: 2024-04-04
Kim Hanjoon Alex
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-04-04+70,183140,366 total
  • Award

    Common Stock

    2024-04-05+70,702211,068 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-04-0470,183140,366 total
    Common Stock (70,183 underlying)
Footnotes (3)
  • [F1]On April 11, 2023, the Reporting Person was granted a target amount of 77,185 performance-based restricted stock units ("RSUs") under the Issuer's 2011 Equity Incentive Plan, as amended. Each RSU represent the right, upon achievement of certain pre-established performance criteria, to receive one share of the Issuer's common stock, subject to vesting conditions. On April 5, 2024, the Board of Directors of the Issuer determined that certain of the RSU performance-based conditions were met resulting in the vesting of 70,702 RSUs as of March 31, 2024.
  • [F2]Each RSU represents the contingent right to receive one share of the Issuer's common stock.
  • [F3]On April 4, 2022, the Reporting Person was granted 280,732 RSUs, vesting in four equal annual installments beginning on April 4, 2023.

Documents

1 file

Issuer

STANDARD BIOTOOLS INC.

CIK 0001162194

Entity typeother

Related Parties

1
  • filerCIK 0001919209

Filing Metadata

Form type
4
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 6:58 PM ET
Size
9.0 KB